"Le centre hospitalier de Roanne, situé au nord-est de la région Rhône Alpes (territoire de santé ouest), est l’hôpital de référence du bassin de santé roannais, qui s’adresse à une population d’environ 150 000 habitants. Le champ de ce bassin couvre la moitié nord du département de la Loire jusqu’à la zone frontalière nord est du département du Rhône, et s’étend sur le sud de la Saône-et-Loire, jusqu’aux environs de Paray-le-Monial. L’hôpital de Roanne constitue aujourd’hui un remarquable outil de travail au service de la population, avec toutes les garanties en termes de confort. Ces rénovations contribuent à une image attractive, renforcée par le rajeunissement récent des équipes de professionnels médicaux et paramédicaux."

During the past decade, Centre Hospitalier de Roanne conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Roanne" #1 sponsor was "Centre Hospitalier Universitaire de Saint Etienne" with 12 trials, followed by "UNICANCER" with 6 trials sponsored, "Centre Hospitalier de Roanne" with 2 trials sponsored, "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored and "Institut de Cancérologie de la Loire" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Roanne" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang" with 2 trials as a collaborator, "Centre Hospitalier Universitaire de Saint Etienne" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BOIRON" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Roanne" are "Breast Cancer" (4 trials), "Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Prostate Cancer" (2 trials) and "Sars-CoV2" (2 trials). Many other conditions were trialed in "Centre Hospitalier de Roanne" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Roanne" are "Drug" (14 trials), "Other" (11 trials), "Biological" (5 trials), "Device" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (3 trials), "Placebo" (2 trials), "adjuvant therapy" (2 trials), "epirubicin hydrochloride" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Roanne" are 35 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Roanne". 1 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Centre Hospitalier de Roanne, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Roanne, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".